| Financial Year |
March 31 2023 |
| Monetary Funds |
315,436,748.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,374,265.23 |
| Accounts Receivable |
192,648,889.30 |
| Advances to Suppliers |
59,936,067.57 |
| Other Receivables |
68,073,762.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
201,765,212.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,160,580.92 |
| Total Current Assets |
900,261,562.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
373,412,100.16 |
| Fixed Assetes |
1,281,492,104.03 |
| Under-construction Projects |
32,037,988.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
262,994,909.43 |
| R&D expenses |
6,301,999.86 |
| Goodwill |
290,036,035.78 |
| Long-Term Deferred and Prepaid Expenses |
24,359,582.85 |
| Deferred Income Tax Assets |
10,329,175.03 |
| Other Non-Current Assets |
388,702,700.06 |
| Sub-Total of Non-Current Assets |
2,849,386,285.15 |
| Total Assets |
3,749,647,847.84 |
| Short-Term Loans |
531,640,378.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
210,725,368.44 |
| Accounts Received In Advance |
14,611,203.79 |
| Employee Compensation Payable |
32,821,515.22 |
| Taxes Payable |
56,135,955.31 |
| Interest Payable |
-- |
| Dividend Payable |
213,880.00 |
| Other payables |
393,780,970.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,528,843.38 |
| Other Current Liabilities |
2,088,956.88 |
| Sub-Total of Current Liabilities |
1,319,958,785.06 |
| Long-term Loans |
452,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,526,370.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,156,770.55 |
| Deferred Income Tax Liabilities |
27,140,851.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
629,139,146.80 |
| Total Liabilities |
1,949,097,931.86 |
| Paid-In Capital(Or Share Stock) |
295,032,402.00 |
| Capital Surplus |
959,611,452.12 |
| Surplus Reserve |
84,481,291.13 |
| LESS:Treasury Stock |
45,001,475.28 |
| Undistributed Profits |
-- |
| Minority Stockholder's Interest |
115,748,860.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,684,801,055.24 |
| Owner's Equity（Stockholder's Equity） |
1,800,549,915.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,749,647,847.84 |
